180 related articles for article (PubMed ID: 35005644)
1. Optimized protocols for efficient gene editing in mouse hepatocytes
Chen Y; Ding Q
STAR Protoc; 2022 Mar; 3(1):101062. PubMed ID: 35005644
[TBL] [Abstract][Full Text] [Related]
2. Optimized protocol for gene editing in adipocytes using CRISPR-Cas9 technology.
Qiu Y; Ding Q
STAR Protoc; 2021 Mar; 2(1):100307. PubMed ID: 33554142
[TBL] [Abstract][Full Text] [Related]
3. A user-friendly and streamlined protocol for CRISPR/Cas9 genome editing in budding yeast.
Novarina D; Koutsoumpa A; Milias-Argeitis A
STAR Protoc; 2022 Jun; 3(2):101358. PubMed ID: 35712010
[TBL] [Abstract][Full Text] [Related]
4. Optimized CRISPR/Cas9-mediated single nucleotide mutation in adherent cancer cell lines.
Gao P; Dong X; Wang Y; Wei GH
STAR Protoc; 2021 Jun; 2(2):100419. PubMed ID: 33870225
[TBL] [Abstract][Full Text] [Related]
5. Efficient CRISPR-Cas9-mediated genome editing for characterization of essential genes in
Picchi-Constante GFA; Hiraiwa PM; Marek M; Rogerio VZ; Guerra-Slompo EP; Romier C; Zanchin NIT
STAR Protoc; 2022 Jun; 3(2):101324. PubMed ID: 35496799
[TBL] [Abstract][Full Text] [Related]
6. Optimized protocol to create deletion in adherent cell lines using CRISPR/Cas9 system.
Farooq U; Notani D
STAR Protoc; 2021 Dec; 2(4):100857. PubMed ID: 34746853
[TBL] [Abstract][Full Text] [Related]
7. Rapid Disruption of Genes Specifically in Livers of Mice Using Multiplex CRISPR/Cas9 Editing.
Pankowicz FP; Barzi M; Kim KH; Legras X; Martins CS; Wooton-Kee CR; Lagor WR; Marini JC; Elsea SH; Bissig-Choisat B; Moore DD; Bissig KD
Gastroenterology; 2018 Dec; 155(6):1967-1970.e6. PubMed ID: 30170115
[TBL] [Abstract][Full Text] [Related]
8. Genome Editing of Murine Liver Hepatocytes by AAV Vector-Mediated Expression of Cas9 In Vivo.
Kashiwakura Y; Ohmori T
Methods Mol Biol; 2023; 2637():195-211. PubMed ID: 36773148
[TBL] [Abstract][Full Text] [Related]
9. Acute gene inactivation in the adult mouse liver using the CRISPR-Cas9 technology.
Wang X; Xu BL; Chen XW
STAR Protoc; 2021 Sep; 2(3):100611. PubMed ID: 34189476
[TBL] [Abstract][Full Text] [Related]
10. CRISPR/Cas9-mediated genome engineering: an adeno-associated viral (AAV) vector toolbox.
Senís E; Fatouros C; Große S; Wiedtke E; Niopek D; Mueller AK; Börner K; Grimm D
Biotechnol J; 2014 Nov; 9(11):1402-12. PubMed ID: 25186301
[TBL] [Abstract][Full Text] [Related]
11. In Vivo Editing of the Adult Mouse Liver Using CRISPR/Cas9 and Hydrodynamic Tail Vein Injection.
Niola F; Dagnæs-Hansen F; Frödin M
Methods Mol Biol; 2019; 1961():329-341. PubMed ID: 30912055
[TBL] [Abstract][Full Text] [Related]
12. Generating mutant
Li HH; Li JC; Su MP; Liu KL; Chen CH
STAR Protoc; 2021 Jun; 2(2):100432. PubMed ID: 33899015
[TBL] [Abstract][Full Text] [Related]
13. Methods for In Vivo CRISPR/Cas Editing of the Adult Murine Retina.
Hung SS; Li F; Wang JH; King AE; Bui BV; Liu GS; Hewitt AW
Methods Mol Biol; 2018; 1715():113-133. PubMed ID: 29188510
[TBL] [Abstract][Full Text] [Related]
14. CRISPR-Cas9 Ribonucleoprotein-Mediated Genomic Editing in Primary Innate Immune Cells.
Hildreth AD; Riggan L; O'Sullivan TE
STAR Protoc; 2020 Dec; 1(3):100113. PubMed ID: 33377009
[TBL] [Abstract][Full Text] [Related]
15. Protocol for gene characterization in Aspergillus niger using 5S rRNA-CRISPR-Cas9-mediated Tet-on inducible promoter exchange.
Zheng X; Cairns T; Zheng P; Meyer V; Sun J
STAR Protoc; 2022 Dec; 3(4):101838. PubMed ID: 36595926
[TBL] [Abstract][Full Text] [Related]
16. FACS-assisted CRISPR-Cas9 genome editing of human induced pluripotent stem cells.
Caillaud A; Lévêque A; Thédrez A; Girardeau A; Canac R; Bray L; Baudic M; Barc J; Gaborit N; Lamirault G; Gardie B; Idriss S; Rimbert A; Le May C; Cariou B; Si-Tayeb K
STAR Protoc; 2022 Dec; 3(4):101680. PubMed ID: 36115027
[TBL] [Abstract][Full Text] [Related]
17. In Vivo AAV-CRISPR/Cas9-Mediated Gene Editing Ameliorates Atherosclerosis in Familial Hypercholesterolemia.
Zhao H; Li Y; He L; Pu W; Yu W; Li Y; Wu YT; Xu C; Wei Y; Ding Q; Song BL; Huang H; Zhou B
Circulation; 2020 Jan; 141(1):67-79. PubMed ID: 31779484
[TBL] [Abstract][Full Text] [Related]
18. A protocol for efficient CRISPR-Cas9-mediated knock-in in colorectal cancer patient-derived organoids.
Okamoto T; Natsume Y; Yamanaka H; Fukuda M; Yao R
STAR Protoc; 2021 Dec; 2(4):100780. PubMed ID: 34585151
[TBL] [Abstract][Full Text] [Related]
19. CRISPR-Cas9 Targeting of PCSK9 in Human Hepatocytes In Vivo-Brief Report.
Wang X; Raghavan A; Chen T; Qiao L; Zhang Y; Ding Q; Musunuru K
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):783-6. PubMed ID: 26941020
[TBL] [Abstract][Full Text] [Related]
20. Genome editing in
Sinha T; Yazdani SS
STAR Protoc; 2022 Sep; 3(3):101629. PubMed ID: 36042883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
